Frontiers in Oncology | Cancer Immunity and Immunotherapy

Correction

Published on 13 Aug 2025

Correction: Enhanced anti−tumor efficacy of “IL−15 and CCL19” −secreting CAR−T cells in human glioblastoma orthotopic xenograft model

in Cancer Immunity and Immunotherapy

Wanqiong Chen
Limian Hong
Shaomei Lin
Na Xian
Cailing Yan
Ningning Zhao
Yonglei Xiao
Wanting Liao
Yuxiang Huang
Mingzhu Chen

Frontiers in Oncology

doi 10.3389/fonc.2025.1645247

144 views

Original Research

Published on 13 Aug 2025

Extracellular matrix-related genes-based prognostic signature for cervical cancer: association of LAMA4 expression with prognosis and response to immunotherapy

in Cancer Immunity and Immunotherapy

Fengchun Gao
Hongyu Shi
Huanhuan Wang
Jin Wang
Dongdong Hao
Yichen Fang

Frontiers in Oncology

doi 10.3389/fonc.2025.1562115

135 views

Original Research

Published on 13 Aug 2025

Clinical features and risk factors of immune-mediated liver injury in non-small cell lung cancer patients treated with immune checkpoint inhibitors

in Cancer Immunity and Immunotherapy

Ling Yang
Chao Zhuo
Chonghuan Li
Yujing Liu
Xinyi Liu
Yibin Huang
Bingbing Wu
Jiawei Su

Frontiers in Oncology

doi 10.3389/fonc.2025.1575376

119 views

Original Research

Published on 13 Aug 2025

Reporting of immune-related adverse events in US Food and Drug Administration approvals of immune checkpoint inhibitors

in Cancer Immunity and Immunotherapy

Shaili Tapiavala
Chongliang Luo
Mina Shenouda
Vaibhav Patel
Andrew A. Davis

Frontiers in Oncology

doi 10.3389/fonc.2025.1606599

129 views

Original Research

Published on 12 Aug 2025

Comprehensive single-cell sequencing reveals the tumor microenvironment and tumor-specific characteristics in trachea squamous cell carcinoma

in Cancer Immunity and Immunotherapy

Hongwu Wang
Hongli Li
Heng Zou
Han Meng
Yan Liu
Chengjun Ban
Weixia Yu
Miao Cheng
Jun Teng

Frontiers in Oncology

doi 10.3389/fonc.2025.1575647

299 views

Mini Review

Published on 08 Aug 2025

Impact of sympathetic nervous system on immune evasion in high-grade serous ovarian cancer: a review

in Cancer Immunity and Immunotherapy

Ruiyuan Yu
Yumeng Li
Runze Jiang
Chunxiao Dang
Fengting Zhai

Frontiers in Oncology

doi 10.3389/fonc.2025.1644895

502 views

Original Research

Published on 08 Aug 2025

CD9 regulates proliferation, invasion, migration and radioresistance of esophageal squamous cell carcinoma by activating AKT/GSK3β signaling pathway

in Cancer Immunity and Immunotherapy

Liubing Hou
Zengyao Hao
Ge Zhang
Jiayuan Li
Yu Wang
Xiaoying Xue
Huandi Zhou

Frontiers in Oncology

doi 10.3389/fonc.2025.1625120

356 views

Study Protocol

Published on 08 Aug 2025

Total neoadjuvant chemoradiotherapy plus anti PD-1 for mid-to-low locally advanced rectal cancer: study protocol of a prospective, single arm, phase II study (STARS - RC06)

in Cancer Immunity and Immunotherapy

Meichen Gu
Yuchen Guo
Liang He
Xuan Sun
Tingting Liang
Zhuo Wang
Ying Li
Zheng Liu
Jingyu Wang
Xiang Qiu

Frontiers in Oncology

doi 10.3389/fonc.2025.1594927

356 views

Original Research

Published on 08 Aug 2025

Multiplexed immune profiling and 3D co-culture assays to assess the individual checkpoint therapy response in head and neck squamous cell carcinoma

in Cancer Immunity and Immunotherapy

Verena Schweihofer
Daniela Schulz
Raquel Blazquez
Gero Brockhoff
Tobias Ettl
Mathias Fiedler
Sina Heimer
Juliane Schikora
Richard J. Bauer
Anja Kathrin Wege

Frontiers in Oncology

doi 10.3389/fonc.2025.1622008

284 views

Original Research

Accepted on 07 Aug 2025

Claudin18.2 Defines a Prognostically Distinct Subgroup of Intrahepatic Cholangiocarcinoma via CD8 + T-Cell Exclusion

in Cancer Immunity and Immunotherapy

Chengui Yu
Yuren Pan
Fuli Li
Zhenyun Guo
Da Xu
Ying Zhu
Baobing Yin

Frontiers in Oncology

doi 10.3389/fonc.2025.1636367

128 views

Study Protocol

Published on 06 Aug 2025

Trial in progress: phase I study of non-viral gene-modified CAR-T cell therapy for malignant solid tumors expressing EPHB4 receptor (CARTiEr)

in Cancer Immunity and Immunotherapy

Chikako Funasaka
Yoichi Naito
Hitomi Kubota
Yukiko Ishiguro
Nozomu Fuse
Masashi Wakabayashi
Akihiro Sato
Junichiro Yuda
Genichiro Ishii
Toshihiro Suzuki

Frontiers in Oncology

doi 10.3389/fonc.2025.1633324

562 views

Case Report

Accepted on 04 Aug 2025

Curative effect and mechanism of sovantinib combined with toripalimab in the treatment of 1 case of lung large-cell neuroendocrine carcinoma

in Cancer Immunity and Immunotherapy

Shuanglong Xiong
Chengxiang Yang
Kaiwen Fu
Xingyun Liao
Yao Ding
Kexue Zhou
Li Zhang
Yan Teng
Chunlan Wu
Yongsheng Li

Frontiers in Oncology

doi 10.3389/fonc.2025.1527719

160 views

Systematic Review

Published on 04 Aug 2025

Systematic literature review of real-world evidence on overall survival in cancer patients before and after the approval of anti-PD-(L)1 therapy

in Cancer Immunity and Immunotherapy

Dweeti Nayak
Katherine G. Akers
Andrew M. Frederickson
Yves P.V. Mbous
Raquel Aguiar-Ibáñez

Frontiers in Oncology

doi 10.3389/fonc.2025.1615795

629 views

Mini Review

Accepted on 31 Jul 2025

Research Advances in Immune Agonists and Their Nanoparticles for Enhancing the Immunotherapeutic Efficacy of PD-1 Inhibitors in Malignancies

in Cancer Immunity and Immunotherapy

Renjie Xia
Juan Liang
Jianguo Ma
Xiaoyu Du
Liangbin Ma
Xiongxiong Han
Yong Wang
Jianwei Qin
Long Yan

Frontiers in Oncology

doi 10.3389/fonc.2025.1618903

148 views

Brief Research Report

Accepted on 31 Jul 2025

Effectiveness and safety of nivolumab and ipilimumab in older adults with renal cell carcinoma: findings from a multicenter observational study in Poland

in Cancer Immunity and Immunotherapy

Artur Drobniak
Łukasz Stokłosa
Aleksandra Grela-Wojewoda
Jacek Calik
Natalia Versuti Viegas
Jolanta Dobrzańska
Agnieszka Roman
Marek Szwiec
Anna Bidas
Daria Tusień-Małecka

Frontiers in Oncology

doi 10.3389/fonc.2025.1617743

167 views

Case Report

Accepted on 29 Jul 2025

Safety and clinical efficacy of immune checkpoint inhibitors in pediatric hepatocellular carcinoma: a case report and review of the literature

in Cancer Immunity and Immunotherapy

Xiaoting Zhong
Xuejiao Wen
Xinping Wang
Jianming Ye
Li Huang
Jing Wang
Jun Chi
Xiaoli Zeng

Frontiers in Oncology

doi 10.3389/fonc.2025.1576892

169 views